LONDON BROKER RATINGS: Wells Fargo 'overweight' on Rolls-Royce
(Alliance News) - The following London-listed shares received analyst recommendations on Wednesday morning and on Tuesday: Read More
| Price | 87.94p on 01-04-2026 at 10:37:53 |
|---|---|
| Change | -0.78p -0.88% |
| Buy | 88.02p |
| Sell | 87.96p |
| Last Trade: | Buy 2,000.00 at 88.005p |
| Day's Volume: | 16,730,822 |
| Last Close: | 88.72p |
| Open: | 90.62p |
| ISIN: | GB0008782301 |
| Day's Range | 87.50p - 91.64p |
| 52wk Range: | 84.32p - 123.85p |
| Market Capitalisation: | £3.09b |
| VWAP: | 88.71377p |
| Shares in Issue: | 3.52b |
Taylor Wimpey (TW.) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 2,000 | 88.005p | Ordinary |
11:37:33 - 01-Apr-26 |
| Buy* | 50 | 88.02p | SI Trade |
11:37:18 - 01-Apr-26 |
| Sell* | 1,881 | 87.94p | Automatic Execution |
11:36:57 - 01-Apr-26 |
| Unknown* | 396 | 87.94p | SI Trade |
11:36:36 - 01-Apr-26 |
| Sell* | 4,041 | 87.92p | Automatic Execution |
11:36:16 - 01-Apr-26 |
| Sell* | 115 | 87.92p | SI Trade |
11:36:13 - 01-Apr-26 |
| Buy* | 113 | 87.98p | SI Trade |
11:36:02 - 01-Apr-26 |
| Sell* | 3,546 | 87.98p | Automatic Execution |
11:35:59 - 01-Apr-26 |
| Buy* | 894 | 87.98p | Automatic Execution |
11:35:59 - 01-Apr-26 |
| Buy* | 2,216 | 87.98p | Automatic Execution |
11:35:59 - 01-Apr-26 |
Taylor Wimpey (TW.) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 30th Mar 2026 2:19 pm | RNS | Holding(s) in Company |
| 26th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 25th Mar 2026 3:00 pm | RNS | Director/PDMR Shareholding |
| 23rd Mar 2026 2:22 pm | RNS | Holding(s) in Company |
| 20th Mar 2026 3:37 pm | RNS | Annual Financial Report and Notice of Meeting |
| 19th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 12th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 10th Mar 2026 3:23 pm | RNS | Director/PDMR Shareholding |
| 10th Mar 2026 3:23 pm | RNS | Director/PDMR Shareholding |
| 6th Mar 2026 11:44 am | RNS | Director/PDMR Shareholding |